847672-84-8Relevant academic research and scientific papers
Click Variations on the Synthesis of 2-Nitrophenyl-4-aryl-1,2,3-triazoles without Isolation of 2-Nitrophenyl Azides
Cisnetti, Federico,Roux, Amélie
supporting information, p. 610 - 614 (2020/03/27)
We report a series of efficient procedures to prepare 2-nitrophenyl-4-aryl-1,2,3-triazoles avoiding the isolation of potentially hazardous 2-nitrophenyl azides. An organocatalyzed azide-enolate variant allows efficient access to the target compounds while
SNAr azidation of phenolic functions utilizing diphenyl phosphorazidate
Ishihara, Kotaro,Shioiri, Takayuki,Matsugi, Masato
supporting information, (2019/12/27)
A useful method for the synthesis of aryl azides via SNAr reaction of phenol derivatives using diphenyl phosphorazidate (DPPA) as an azidation reagent was developed. Various phenol derivatives bearing electron-withdrawing groups were converted into the corresponding aryl azides in a single step. This method is easy to perform and enables the preparation of aryl azides without the use of explosive azide sources.
Click 1,2,3-triazole derived fluorescent scaffold by mesoionic carbene-nitrene cyclization: an experimental and theoretical study
Bouchemella, Khadidja,Fauché, Kévin,Anak, Barkahem,Jouffret, Laurent,Bencharif, Mustapha,Cisnetti, Federico
, p. 18969 - 18978 (2018/11/26)
We describe a set of three fluorescent mesoionic benzo[4,5]imidazo-3-ide-[1,2-c]-2-alkyl-1,2,3-triazol-2-ium compounds obtained through a simple, concise and efficient synthetic sequence featuring a copper-catalyzed carbene-nitrene cyclization. The compou
Furazan-containing bromoarenes in the Suzuki-Miyaura reaction
Vasil'ev,Struchkova,Sheremetev,Levinson,Varganov,Lyssenko
, p. 2306 - 2314 (2012/10/30)
The palladium-catalyzed cross-coupling reactions of 3-[bromo(het)aryl] furazans and bromobenzofurazans with arylboronic acids afford target biaryls in good yields. 3-Bromo-4-phenylfurazan containing a bromine atom in the furazan ring undergoes decomposition under the reaction conditions.
FACTOR XA INHIBITORS
-
Page/Page column 82, (2008/12/07)
The present invention is directed to compounds represented by Formula (I) or a pharmaceutically acceptable salt, ester, or prodrug thereof which are inhibitors of Factor Xa. The present invention is also directed to intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat certain conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.
